Cancer and the spouse: gender-related differences in dealing with health care and illness

Baider, Lea; Bengel, Juergen

doi:10.1016/s1040-8428(01)00137-8

Cited by 65 publications

(45 citation statements)

References 49 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The existing body of work on family caregivers of cancer survivors focuses primarily on the caregiver's adjustment during the early survivorship phase. Furthermore, some of the major problems in the existing research include small sample sizes (with some exceptions 14,73 ), cross-sectional study designs (with some exceptions 29,[31][32][33]156,157 ), and examining only survivors' or caregivers' QOL, and not both (with certain exceptions 33,73,74 ). Issues about small sample sizes often involve convenient rather than representative sampling methods and descriptive rather than theory-testing research, which limit the validity and generalizability of findings.…”

Section: Methodological Concernsmentioning

confidence: 99%

“…Compared with husbands of women with no cancer or other chronic or acute illness, husbands of women undergoing chemotherapy for breast cancer reported poorer mental health. 30 Demographic and psychosocial characteristics associated with the caregiver's distress (ie, depression, general psychological distress, and cancer-specific distress) include being a woman, 29,[31][32][33] younger age, 34,35 spousal caregivers, [36][37][38] lower socioeconomic status, 37,39 employed, 5,36 and lack of personal and social support. 9,36,40,41 Factors specific to the caregiving situation that also are related to caregiver's distress include caregiving burden, 42,43 self-efficacy for caregiving, 44 types of care provided, 8,45 and the survivor's functional status.…”

Section: Family Caregivers' Qol At the Acute Survivorship Phasementioning

confidence: 99%

See 1 more Smart Citation

Quality of life of family caregivers of cancer survivors

Kim

Given

2008

Cancer

410

342

View full text Add to dashboard Cite

Objective: The aim of this pilot study was to determine whether early atorvastatin treatment will reduce left ventricle (LV) remodeling, infarct size, and improve microvascular perfusion. Background: In animal studies, early statin therapy reduces reperfusion injury after a percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI). Methods: Forty‐two consecutive patients (82% male, mean age 61.2 ± 9.8) who underwent a primary PCI for a first ST‐elevated AMI were randomized for pretreatment with atorvastatin 80 mg (n = 20) or placebo (n = 22) and continued with the same dosage daily for 1 week. All patients received atorvastatin 80 mg once daily 7 days after primary PCI. The LV function and infarct size were measured by magnetic resonance imaging within 1 day, at 1 week, and 3 months follow up. The primary endpoint was the end‐systolic volume index (ESVI) at 3 months. Secondary endpoints were global LV function measurements, myocardial infarct size, biochemical cardiac markers, TIMI flow, and ST‐T elevation resolution. Results: ESVI 3 months after AMI was 25.1 mL/m2 in the atorvastatin arm and 25.0 mL/m2 in the placebo arm (P = 0.74). The differences in change from baseline to 3 months follow up in global LV function and myocardial infarct size did not differ between both treatment arms. Furthermore, biochemical markers, TIMI flow, and ST‐T elevation resolution did not differ between atorvastatin and placebo arm. Conclusions: In this pilot study, pretreatment with atorvastatin in an acute myocardial infarction does not result in an improved cardiac function, microvascular perfusion, or decreased myocardial infarct size. © 2012 Wiley Periodicals Inc.

show abstract

Section: Methodological Concernsmentioning

confidence: 99%

Section: Family Caregivers' Qol At the Acute Survivorship Phasementioning

confidence: 99%

Quality of life of family caregivers of cancer survivors

Kim

Given

2008

Cancer

410

342

View full text Add to dashboard Cite

show abstract

“…In summary, the literature indicates there are gender distinctions not only in biological processes, but also in relation to life conditions, environmental experiences, risk behavior, and response to stressors (Baider & Bengel, 2001;Rezende et al, 2010). Such evidence needs to be better known because the prevalence of cancer in the world population has not receded.…”

Section: Gender and Cancermentioning

confidence: 99%

Assessment of Distress Among Chemotherapy Patients: A Comparative Study of Gender

Bergerot¹,

Araújo²,

Tróccoli³

2014

Paidéia (Ribeirão Preto)

View full text Add to dashboard Cite

The aim of this study was to evaluate, analyze and understand distress levels experienced during chemotherapy treatment, comparing men and women. The sample was composed of 328 patients recruited from an Oncology center. Data collection included the application of the Distress Thermometer at three stages of chemotherapy: beginning, middle and end. Incidence of distress decreased in both genders over the course of assessments. Comparatively, the incidence was higher among women, who also reported the highest number of problems in the practical, family, emotional, spiritual and physical domains. The results corroborate the international literature on the subject. Clinical interest of systematic assessment of distress was confirmed to develop routines of therapeutic monitoring adapted to the specific needs of cancer patients.

show abstract

“…Once again, this finding demonstrates a gender difference in disease manifestation and response to medical treatment in cancer patients (24). The National Institutes of Health State-of-the-Science conference statement on improving end-of-life care suggested that subgroups of race, ethnicity, culture, gender, age and disease states experience end-of-life care differently, and that these differences remain poorly understood (25).…”

mentioning

confidence: 98%

Evaluation of Inpatient Multidisciplinary Palliative Care Unit on Terminally Ill Cancer Patients from Providers' Perspectives: A Propensity Score Analysis

Cheng

Fang

et al. 2012

Japanese Journal of Clinical Oncology

View full text Add to dashboard Cite

Objective: The effectiveness of inpatient palliative care units, a complex intervention, is challenging to evaluate due to methodological and practical difficulties. We conducted a study to evaluate providers' perceived effectiveness of one such unit. Methods: A non-concurrent, prospective, controlled study using the Audit Scale for good death services as an indicator of process of care and the Good Death Scale as the outcome of provider assessment of quality of dying was conducted. Eighty of 212 terminally ill cancer patients were matched from a tertiary medical center in Taiwan. Patients in the unit served as the intervention group and patients in the oncology ward served as controls. Multiple logistic regression was applied to estimate the propensity of choosing the unit for each patient, and linear regression analysis was conducted to identify predictive factors for mean change scores of the Good Death Scale. Results: Male gender (P , 0.001, 95% confidence interval ¼ 0.73-2.43) was associated with better quality of dying while having hepatocellular carcinoma (P , 0.004, 95% confidence interval ¼ 22.22 to 20.44) was associated with worse quality. For those in the unit, higher total Audit Scale scores were positively related to the outcome of quality of dying. The unit (P , 0.001, 95% confidence interval ¼ 8.67-12.97) and higher Good Death Scale at admission (P , 0.001, 95% confidence interval ¼ 0.44-1.13) were predictors of Audit Scale scores. Conclusions: Admission to a palliative care unit was associated with higher provider assessments of quality of dying for terminally ill cancer patients. These units should be considered as options for hospitals looking for ways to improve the quality of dying for patients.

show abstract

Cancer and the spouse: gender-related differences in dealing with health care and illness

Cited by 65 publications

References 49 publications

Quality of life of family caregivers of cancer survivors

Quality of life of family caregivers of cancer survivors

Assessment of Distress Among Chemotherapy Patients: A Comparative Study of Gender

Evaluation of Inpatient Multidisciplinary Palliative Care Unit on Terminally Ill Cancer Patients from Providers' Perspectives: A Propensity Score Analysis

Contact Info

Product

Resources

About